undamentalytics Newsletter
Sign in

Treace Medical Concepts, Inc. cash flow statement

In fiscal 2025, Treace Medical Concepts, Inc.'s operations generated −$16.0m of cash; it spent $13.5m on capital projects, leaving free cash flow of −$29.5m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−8−4−17−31−35−37−16−15
Depreciation and amortisation111258118
Stock-based pay113817313430
Capital spending1131511121410
Free cash flow−9−6−20−45−46−49−29−25
Free cash flow after stock pay−10−6−23−54−63−79−63−55

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: SIBN vs TMCILAKE vs TMCIESTA vs TMCI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Treace Medical Concepts, Inc.